Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06545188
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-15
Brief Title:
Impact of Mortality Salience on Treatment Decisions
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Impact of Mortality Salience on Treatment Decisions
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MOST-D
Brief Summary:
The goal of this clinical trial is to learn if mortality salience has an impact on treatment decisions in urologists and patients with urological cancer The main questions it aims to answer are
Does mortality salience lead to more aggressive treatment decisions in a urologists and b patients with urological cancer Which factors predict more aggressive treatment decisions a in urologists and b in patients with urological cancer Is the Fear of cancer recurrence-1 FCR-1 in German language a valid screening tool for fear of cancer progression in patients with urological cancer
Researchers will compare a mortality salience trigger to control questions to see if mortality salience leads to more aggressive treatment decisions
Participants will
Answer the Mortality Attitudes Personality survey MAPS to trigger mortality salience and in three borderline case vignettes provide information on how likely they would be to choose a more aggressive therapy
Does mortality salience lead to more aggressive treatment decisions in a urologists and b patients with urological cancer Which factors predict more aggressive treatment decisions a in urologists and b in patients with urological cancer Is the Fear of cancer recurrence-1 FCR-1 in German language a valid screening tool for fear of cancer progression in patients with urological cancer
Researchers will compare a mortality salience trigger to control questions to see if mortality salience leads to more aggressive treatment decisions
Participants will
Answer the Mortality Attitudes Personality survey MAPS to trigger mortality salience and in three borderline case vignettes provide information on how likely they would be to choose a more aggressive therapy
Detailed Description:
Background Harmful overtreatment is a major problem in oncology Unconscious fear of death mortality salience could increase the likelihood of a physician or patient decision in favor of aggressive therapy and thus contribute to overtreatment
Methods Conduction of two randomized controlled trials 1 online survey of n 260 urological patients 2 paper questionnaire survey of n 260 urological cancer inpatients Intervention group triggering of mortality salience with two open questions on death control group two open questions on dental treatment The primary endpoint is the probability of opting for aggressive treatment in three questions on a treatment decision Likert scale from 0 to 10 In both studies the evaluation is carried out as a comparison of means using a two-sided t-test Secondary endpoints are further factors associated with a decision in favor of aggressive therapy
Result An increase in the probability of a decision in favor of the more aggressive therapy as a result of triggering mortality salience is expected with an effect size of d 35
Discussion In order to avoid harmful overtreatment due to unconscious fear of death doctors could undergo training to deal with their existential fears - this could take place as part of communication training For cancer patients this confrontation can take place as part of psycho-oncology training
Methods Conduction of two randomized controlled trials 1 online survey of n 260 urological patients 2 paper questionnaire survey of n 260 urological cancer inpatients Intervention group triggering of mortality salience with two open questions on death control group two open questions on dental treatment The primary endpoint is the probability of opting for aggressive treatment in three questions on a treatment decision Likert scale from 0 to 10 In both studies the evaluation is carried out as a comparison of means using a two-sided t-test Secondary endpoints are further factors associated with a decision in favor of aggressive therapy
Result An increase in the probability of a decision in favor of the more aggressive therapy as a result of triggering mortality salience is expected with an effect size of d 35
Discussion In order to avoid harmful overtreatment due to unconscious fear of death doctors could undergo training to deal with their existential fears - this could take place as part of communication training For cancer patients this confrontation can take place as part of psycho-oncology training
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None